Data Composite

Drug Recalls

Recent drug recall reports from the FDA (US) and Health Canada, newest first. Each entry links to the full record -- product description, reason for recall, and severity classification -- refreshed daily.

Pfizer Inc.

US Class II Ongoing · initiated 2025-05-28

Discoloration; discolored solution from cracked vials

Apotex Corp.

US Class II Ongoing · initiated 2025-05-28

Lack of Assurance of Sterility

JAMP-ASA 81MG EC

Canada Type II Ongoing · initiated 2025-05-28

Product safety. Verify if your product is affected.Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health con…

Torrent Pharma Inc.

US Class II Completed · initiated 2025-05-27

CGMP Deviations: Presence of N-Nitroso Fluoxetine exceeding interim acceptable intake limit.

Torrent Pharma Inc.

US Class II Completed · initiated 2025-05-27

CGMP Deviations: Presence of N-Nitroso Fluoxetine exceeding interim acceptable intake limit.

Fresenius Medical Care Holdings, Inc.

US Class II Ongoing · initiated 2025-05-27

Lack of Assurance of Sterility

Sivem ezetimibe 10 mg tablets

Canada Type I Ongoing · initiated 2025-05-27

Product safety. Check your medication bottle to ensure it only contains Sivem ezetimibe 10 mg tablets.Sivem ezetimibe 10 mg is a white oblong tablet, with “93" …

Consumer Product Partners, LLC

US Class II Ongoing · initiated 2025-05-23

Subpotent product: Product has cloudy appearance and tested below assay label claim for 70% Ethyl Alcohol

Ascend Laboratories, LLC

US Class II Ongoing · initiated 2025-05-23

Failed Impurities/Degradation Specifications An out-of-specification result was observed in the related substance test at the sixth month of stability analysis.…

Ascend Laboratories, LLC

US Class II Ongoing · initiated 2025-05-23

Failed Impurities/Degradation Specifications An out-of-specification result was observed in the related substance test at the sixth month of stability analysis.…

Teva Pharmaceuticals USA, Inc

US Class II Ongoing · initiated 2025-05-23

Presence of foreign tablets/capsules.

Aurobindo Pharma USA Inc

US Class II Ongoing · initiated 2025-05-22

cGMP deviations: Due to confirmed consumer complaints received with the observation of tablet discoloration (brown surface on tablets).

TARO-GLICLAZIDE MR

Canada Type II Ongoing · initiated 2025-05-22

Product safety. Verify if your product is affected.Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health con…

Umary-USA.com

US Class I Completed · initiated 2025-05-21

Marketed without approved NDA/ANDA- Laboratory analysis found product to be tainted with undeclared ingredients: Dexamethasone, Diclofenac and Omeprazole.

Umary-USA.com

US Class I Completed · initiated 2025-05-21

Marketed without approved NDA/ANDA- Laboratory analysis found product to be tainted with undeclared ingredients: Dexamethasone and Diclofenac.

Thrive Health and Wellness, LLC, dba Thrive Health Solutions (Colorado)

US Class II Ongoing · initiated 2025-05-21

Lack of Assurance of Sterility

Thrive Health and Wellness, LLC, dba Thrive Health Solutions (Colorado)

US Class II Ongoing · initiated 2025-05-21

Lack of Assurance of Sterility

Thrive Health and Wellness, LLC, dba Thrive Health Solutions (Colorado)

US Class II Ongoing · initiated 2025-05-21

Lack of Assurance of Sterility

Thrive Health and Wellness, LLC, dba Thrive Health Solutions (Colorado)

US Class II Ongoing · initiated 2025-05-21

Lack of Assurance of Sterility

Thrive Health and Wellness, LLC, dba Thrive Health Solutions (Colorado)

US Class II Ongoing · initiated 2025-05-21

Lack of Assurance of Sterility

Thrive Health and Wellness, LLC, dba Thrive Health Solutions (Colorado)

US Class II Ongoing · initiated 2025-05-21

Lack of Assurance of Sterility

Thrive Health and Wellness, LLC, dba Thrive Health Solutions (Colorado)

US Class II Ongoing · initiated 2025-05-21

Lack of Assurance of Sterility

Thrive Health and Wellness, LLC, dba Thrive Health Solutions (Colorado)

US Class II Ongoing · initiated 2025-05-21

Lack of Assurance of Sterility

Thrive Health and Wellness, LLC, dba Thrive Health Solutions (Colorado)

US Class II Ongoing · initiated 2025-05-21

Lack of Assurance of Sterility

Thrive Health and Wellness, LLC, dba Thrive Health Solutions (Colorado)

US Class II Ongoing · initiated 2025-05-21

Lack of Assurance of Sterility